Literature DB >> 15542815

Complications of therapy in cancer patients: Case 1. Paronychia and skin hyperpigmentation induced by gefitinib in advanced non-small-cell lung cancer.

Gee-Chen Chang1, Tsung-Ying Yang, Kun-Chieh Chen, Ming-Chang Yin, Ren-Ching Wang, Yung-Chiou Lin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15542815     DOI： 10.1200/JCO.2004.02.168

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  9 in total

1.  The Dark Side of Gefitinib: Reflectance Confocal Microscopy Applied to Hair Hyperpigmentation.

Authors:  Terenzio Cosio; Sara Mazzilli; Luca Bianchi; Elena Campione
Journal:  Skin Appendage Disord       Date:  2019-10-25

Review 2.  Pigmentary changes in patients treated with targeted anticancer agents: A systematic review and meta-analysis.

Authors:  Julia Dai; Viswanath R Belum; Shenhong Wu; Vincent Sibaud; Mario E Lacouture
Journal:  J Am Acad Dermatol       Date:  2017-09-14       Impact factor: 11.527

3.  Adverse events associated with anti-EGFR therapies for the treatment of metastatic colorectal cancer.

Authors:  M Fakih; M Vincent
Journal:  Curr Oncol       Date:  2010-07       Impact factor: 3.677

Review 4.  Drug-induced skin, nail and hair disorders.

Authors:  Laurence Valeyrie-Allanore; Bruno Sassolas; Jean-Claude Roujeau
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

5.  Atypical skin reaction in a patient treated with gefitinib for advanced lung cancer: A case report and review of the literature.

Authors:  Anna Ferrazzi; Irene Russo; Giulia Pasello; Mauro Alaibac
Journal:  Exp Ther Med       Date:  2015-11-19       Impact factor: 2.447

6.  Osimertinib-associated ashy dermatosis-like hyperpigmentation.

Authors:  Pattamon Lertpichitkul; Jade Wititsuwannakul; Pravit Asawanonda; Pawinee Rerknimitr
Journal:  JAAD Case Rep       Date:  2020-01-17

7.  Rare ashy dermatosis-like hyperpigmentation associated with osimertinib.

Authors:  Kazuhito Funai
Journal:  Thorac Cancer       Date:  2022-03-29       Impact factor: 3.223

Review 8.  Epidermal growth factor receptor inhibitors: a review of cutaneous adverse events and management.

Authors:  K Chanprapaph; V Vachiramon; P Rattanakaemakorn
Journal:  Dermatol Res Pract       Date:  2014-03-02

Review 9.  Dermatologic conditions in women receiving systemic cancer therapy.

Authors:  Michelle N Ferreira; Julie Y Ramseier; Jonathan S Leventhal
Journal:  Int J Womens Dermatol       Date:  2019-11-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.